The issue of the feasibility of a general theory of aging. III. Theory and practice of aging
Analysis of demographic data on human mortality and lifespan carried out according to the complete Gompertz-Makeham model μ = C + λeγxt shows that, over the last 100 years, the life expectancy increased almost exclusively because the Makeham parameter C decreased. The observed changes in the demographic aging rate γ and in the initial vitality, which is inversely proportional to lnλ, may be largely an artifact of the attempts to decompose mortality data related to conditions that significantly change within a time scale comparable to the human lifespan, whereas the correct decomposition of mortality change by different Gompertz-Makeham parameters is possible only for a strictly homogeneous population under strictly stationary conditions. What actually remains of changes in these parameters, while theoretically significant, would probably be negligible in the quantitative practical aspect. The comparison of this situation with experiments on animals, suggesting possible interferences that may decrease the aging rate and/or increase the lifespan, reveals that the main factors of reduced mortality and, correspondingly, increased lifespan in human beings are limited to one’s personal commitment to following long-standing and readily available guidelines for healthy life, which may help bring one’s lifespan about 10 years closer to the reliably recorded maximum of 122 years, although they obviously do not guarantee it. The bottleneck for the realization of this reserve resides in public and individual mentality rather than in science.
Unable to display preview. Download preview PDF.
- 1.Anisimov, V.N., Means of Prevention of Premature Aging (Geroprotectors), Usp. Gerontol., 2000, no. 4, pp. 55–73.Google Scholar
- 2.Golubev, A.G., Catecholamines, Steroids, and Aging of the Nervous and Endocrinal Systems, Usp. Sovrem. Biol., 1989, no. 6, pp. 64–75.Google Scholar
- 3.Golubev, A.G., Alzheimer’s Disease, Amiloidoses, and Aging, Usp. Gerontol., 2000, no. 4, pp. 102–112.Google Scholar
- 4.Golubev, A.G., Biochemistry of Life Prolongation, Usp. Gerontol., 2003, no. 12, pp. 57–76.Google Scholar
- 6.Golubev, A.G., The Issue of Feasibility of a General Theory of Aging: II. Parametabolic Theory of Aging, Usp. Gerontol., 2009, no. 2, pp. 205–222.Google Scholar
- 9.Ang, L.S., Cruz, R.P., Hendel, A., and Granville, D.J., Apolipoprotein E, an Important Player in Longevity and Age-Related Diseases, Exp. Gerontol., 2008.Google Scholar
- 12.de la Fuente-Fernandez, R., Impact of Neuroprotection on Incidence of Alzheimer’s Disease, PLoS ONE, 2006, vol. e52. doi: 10.1371/journal.pone.0000052.Google Scholar
- 22.Huang, H.Y., Helzlsouer, K.J., and Appel, L.J., The Effects of Vitamin C and Vitamin E on Oxidative DNA Damage: Results from a Randomized Controlled Trial, Cancer Epidem. Biomarkers Prev., 2000, vol. 9, pp. 647–652.Google Scholar
- 25.la Cour, P., Avlund, K., and Schultz-Larsen, K., Religion and Survival in a Secular Group: A Twenty Year Follow-up of 734 Danish Adults Born in 1914, Soc. Sci. Med., 2006, vol. 62, pp. 167–164.Google Scholar
- 31.Oeppen, J., Life Expectancy Convergence Among Nations since 1820: Separating the Effects of Technology and Income, Perspectives on Mortality Forecasting. III. The Linear Rise in Life Expectancy: History and Prospects, Social Insurance Studies, Bengtsson, T., Ed., Swedish Social Insurance Agency, 2006, no. 3., pp. 55–83.Google Scholar
- 40.Thompson, L.V., Age-Related Muscle Dysfunction, Exp. Geront., 2008, doi: 10.1016/j.exger.2008.05.003.Google Scholar
- 42.Wachter, K.W., Hazard Curves and Life Span Prospects, Pop. Dev. Rev., 2003, vol. 29.Suppl.: Life Span: Evolutionary, Ecological, and Demographic Perspectives, pp. 270–291.Google Scholar
- 43.Wilmoth, J.R. and Robine, J.-M., The World Trend in Maximum Life Span, Popul. Dev. Rev., 2003, vol. 29.Google Scholar